ONPH

Oncology Pharma (PK) Stock Price

36.00
-1.51 (-4.03%)
36.00

Low
0.00395

52 Week Range

High
50.00

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Oncology Pharma Inc (PK) ONPH OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.51 -4.03% 36.00 16:01:06
Open Price Low Price High Price Close Price Prev Close
38.00 30.7501 39.24 36.00 37.51
Bid Price Ask Price Spread News
34.50 36.00 1.50 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,131 105,118 $ 35.1511 $ 3,695,012 - 0.00395 - 50.00
Last Trade Time Type Quantity Stock Price Currency
15:59:51 74 $ 36.00 USD

Oncology Pharma (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 984.18M 27.34M 3.39M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
12.33k $ - 0.00% - -

more financials information »

Oncology Pharma (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ONPH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week31.2041.0221.4033.49218,0784.8015.38%
1 Month21.0041.0219.0029.61105,37815.0071.43%
3 Months1.0650.001.0123.51125,92034.943,296.23%
6 Months0.4150.000.2523.2475,20435.598,680.49%
1 Year0.01650.000.003952.50317,80435.98224,900.0%
3 Years0.0150.000.0031.77246,07335.99359,900.0%
5 Years0.0150.000.0031.77246,07335.99359,900.0%

Oncology Pharma (PK) Description

Oncology Pharma, Inc. is a pioneering oncology company dedicated to licensing, developing, manufacturing and commercializing therapeutics and opportunities within the bio-pharma space. The Company has assembled a team of executives and advisors with a proven multi-disciplinary expertise in the field of cancer therapies, epidemiology and leadership to identify, negotiate and amalgamate "best in class" research, technologies, and drug delivery that are synergistic and collaborative. Oncology Pharma has executed Licensing Agreements with NanoSmart Pharmaceuticals' drug delivery platform, which can target many types of cancer and other diseases;Connect2Med, a powerful application used for recruiting, enrolling and supporting patients for clinical trials. Further information may be found at www.oncology-pharma.com.


Your Recent History
USOTC
ONPH
Oncology P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.